• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同光动力疗法半参数对兔脉络膜视网膜的损伤

The chorioretinal damage caused by different half parameters of photodynamic therapy in rabbits.

作者信息

Chuang Lan-Hsin, Hwang Yih-Shiou, Wang Nan-Kai, Chen Yen-Po, Liu Laura, Yeung Ling, Chen Kuan-Jen, Chen Tun-Lu, Wu Wei-Chi, Lai Chi-Chun

机构信息

1 Department of Ophthalmology, Chang-Gung Memorial Hospital , Keelung, Taiwan .

出版信息

J Ocul Pharmacol Ther. 2014 Oct;30(8):642-9. doi: 10.1089/jop.2013.0219. Epub 2014 Jun 20.

DOI:10.1089/jop.2013.0219
PMID:24949836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4186804/
Abstract

PURPOSE

To compare the chorioretinal tissue response after different half-strength parameters of photodynamic therapy (PDT) in rabbits.

METHODS

The study included 4 groups, and each group contained 4 animals. The full dose served as the control group: verteporfin (4 mg/kg) with 600 mW/cm(2) irradiance from a diode laser at 689 nm applied to the retina for 8 s. One parameter was changed to half-strength in the other 3 groups. The HLaser group received half-strength laser irradiance. The HTime group was exposed to photosensitization for half the time, and the HDose group received half the drug dose. Six laser spots were generated in each of the eyes of every rabbit and documented graphically. The lesions were examined on days 1, 7, and 42 after PDT treatment using color fundus imaging, fluorescein angiography (FA), and histopathology analysis.

RESULTS

PDT treatment in rabbits caused chorioretinal damage in all 4 groups. FA on day 1 showed that the use of half the laser irradiance, half the drug dose, or half the photosensitizing time tended to decrease the damage to the chorioretinal tissue in terms of the number of occlusions and the area of occlusion, but only the results from half the laser irradiance were significantly different. In addition, the HLaser and HDose groups showed significantly less apoptosis by TUNEL staining on day 1.

CONCLUSIONS

Among these PDT parameters, decreasing the laser irradiance by half showed the greatest decrease in chorioretinal damage in an experimental animal model.

摘要

目的

比较不同半强度参数的光动力疗法(PDT)对兔脉络膜视网膜组织的反应。

方法

本研究包括4组,每组4只动物。全剂量组作为对照组:用二极管激光器以689nm波长、600mW/cm²的辐照度将维替泊芬(4mg/kg)照射视网膜8秒。在其他3组中改变一个参数为半强度。HLaser组接受半强度激光辐照。HTime组接受一半时间的光敏化,HDose组接受一半药物剂量。在每只兔的每只眼睛中产生6个激光光斑,并进行图像记录。在PDT治疗后第1、7和42天,使用彩色眼底成像、荧光素血管造影(FA)和组织病理学分析检查病变。

结果

兔的PDT治疗在所有4组中均导致脉络膜视网膜损伤。第1天的FA显示,使用一半的激光辐照度、一半的药物剂量或一半的光敏化时间,在闭塞数量和闭塞面积方面,脉络膜视网膜组织的损伤有减少趋势,但只有一半激光辐照度的结果有显著差异。此外,HLaser组和HDose组在第1天通过TUNEL染色显示凋亡明显较少。

结论

在这些PDT参数中,将激光辐照度降低一半在实验动物模型中显示出脉络膜视网膜损伤减少最多。

相似文献

1
The chorioretinal damage caused by different half parameters of photodynamic therapy in rabbits.不同光动力疗法半参数对兔脉络膜视网膜的损伤
J Ocul Pharmacol Ther. 2014 Oct;30(8):642-9. doi: 10.1089/jop.2013.0219. Epub 2014 Jun 20.
2
Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.新型光敏剂Stakel(WST - 11)用于兔眼和大鼠眼光动力脉络膜血管闭塞的评估。
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1633-44. doi: 10.1167/iovs.07-0767.
3
Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.使用维替泊芬的光动力疗法对治疗后长达7周的实验性脉络膜新生血管以及正常视网膜和脉络膜的影响。
Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2322-31.
4
Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.维替泊芬光动力疗法对食蟹猴正常视网膜和脉络膜的再治疗
Ophthalmology. 1999 Oct;106(10):1915-23. doi: 10.1016/S0161-6420(99)90401-3.
5
Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).用于年龄相关性黄斑变性的高辐照度与光动力疗法(一篇美国眼科学会论文)
Trans Am Ophthalmol Soc. 2008;106:357-82.
6
Sequence of early vascular events after photodynamic therapy.光动力治疗后早期血管事件的序列
Invest Ophthalmol Vis Sci. 2003 May;44(5):2147-54. doi: 10.1167/iovs.02-0604.
7
Photodynamic therapy of experimental choroidal neovascularization in the mouse.小鼠实验性脉络膜新生血管的光动力疗法
Curr Eye Res. 2006 Sep;31(9):765-74. doi: 10.1080/02713680600865045.
8
Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.脂质体苯并卟啉衍生物维替泊芬光动力疗法。对猴子脉络膜新生血管的选择性治疗。
Ophthalmology. 1996 Mar;103(3):427-38. doi: 10.1016/s0161-6420(96)30675-1.
9
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.通过将靶向维替泊芬递送至由归巢肽介导至血管内皮生长因子受体-2的实验性脉络膜新生血管来进行选择性光动力疗法。
Arch Ophthalmol. 2004 Jul;122(7):1002-11. doi: 10.1001/archopht.122.7.1002.
10
Dose-Related Structural Effects of Photodynamic Therapy on Rabbit Choroidal Structure.光动力疗法对兔脉络膜结构的剂量相关结构影响。
Ophthalmic Res. 2021;64(6):1037-1047. doi: 10.1159/000519328. Epub 2021 Sep 10.

引用本文的文献

1
Large animal models for investigating the applications of photodynamic therapy.用于研究光动力疗法应用的大型动物模型。
Zool Res. 2025 May 18;46(3):551-575. doi: 10.24272/j.issn.2095-8137.2024.445.
2
Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft.使用视网膜母细胞瘤异种移植的兔眼间接光动力疗法模型
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2363-2373. doi: 10.1007/s00417-017-3805-8. Epub 2017 Oct 2.
3
Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者接受选择性视网膜治疗(SRT)后的视网膜敏感性
Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):243-254. doi: 10.1007/s00417-016-3441-8. Epub 2016 Aug 6.

本文引用的文献

1
Central serous chorioretinopathy: update on pathophysiology and treatment.中心性浆液性脉络膜视网膜病变:发病机制和治疗的最新进展。
Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004.
2
Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy.氩激光联合与不联合抗血管内皮生长因子治疗中心凹外息肉样脉络膜血管病变。
Am J Ophthalmol. 2013 Feb;155(2):295-304.e1. doi: 10.1016/j.ajo.2012.08.002. Epub 2012 Oct 27.
3
Half-fluence photodynamic therapy in acute central serous chorioretinopathy.急性中心性浆液性脉络膜视网膜病变的半剂量光动力疗法。
Retina. 2012 Nov-Dec;32(10):2014-9. doi: 10.1097/IAE.0b013e318242b9ab.
4
Review of ranibizumab trials for neovascular age-related macular degeneration.雷珠单抗治疗新生血管性年龄相关性黄斑变性试验综述。
Semin Ophthalmol. 2011 Nov;26(6):372-9. doi: 10.3109/08820538.2011.570845.
5
Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial.半剂量维替泊芬光动力疗法治疗中心性浆液性脉络膜视网膜病变的多焦视网膜电图改善:一项随机安慰剂对照试验。
Retina. 2011 Jul-Aug;31(7):1378-86. doi: 10.1097/FTD.0b013e31820beb02.
6
One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.减少强度的光动力疗法治疗息肉样脉络膜血管病变的一年疗效。
Am J Ophthalmol. 2010 Mar;149(3):465-71.e1. doi: 10.1016/j.ajo.2009.09.020. Epub 2009 Dec 30.
7
Blood-assisted internal limiting membrane peeling for macular hole repair.血液辅助内界膜剥除术治疗黄斑裂孔
Ophthalmology. 2009 Aug;116(8):1525-30. doi: 10.1016/j.ophtha.2009.02.025. Epub 2009 Jun 5.
8
Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.息肉状脉络膜血管病变继发的难治性新生血管性年龄相关性黄斑变性
Am J Ophthalmol. 2009 Jul;148(1):70-8.e1. doi: 10.1016/j.ajo.2009.02.012. Epub 2009 Apr 29.
9
Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.息肉状脉络膜血管病变光动力疗法的两年结果
Am J Ophthalmol. 2008 Oct;146(4):513-519. doi: 10.1016/j.ajo.2008.05.025. Epub 2008 Jul 9.
10
Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.半剂量维替泊芬光动力疗法治疗急性中心性浆液性脉络膜视网膜病变:一项随机对照试验的一年结果
Ophthalmology. 2008 Oct;115(10):1756-65. doi: 10.1016/j.ophtha.2008.04.014. Epub 2008 Jun 5.